Refine by
Drug Therapy Articles & Analysis
128 news found
In dermatology, new methods for treating benign epidermal lesions are emerging, alongside the development of drug-free therapies to enhance patient well-being. Surgical innovations, such as advanced transplant surgery instruments and bone cement applications, are optimizing complex procedures. Additionally, exosome-loaded protein-based therapy ...
Utilizing micron-sized needles to administer drugs directly into the skin, the microneedle technology has become a revolutionary tech in the delivery of drugs. ...
Yang, L., et al (2024) introduces LungVis 1.0, an AI-driven imaging platform integrating light sheet fluorescence microscopy (LSFM) and deep learning for mapping nanoparticle (NP) deposition across murine lungs. The research highlights the advantages of aerosol-based delivery methods over traditional liquid-based approaches, emphasizing the uniformity of NP deposition in distal alveolar ...
In addition to a variety of experimental animals including mice, rats, rabbits, and monkeys, Ace Therapeutics can assist worldwide clients in constructing custom animal models using techniques such as environmental enrichment, gene editing, dietary modifications, or drug therapies. Moreover, the company can also provide researchers with cardiac organoid models ...
“Whether customers are trying to develop a new drug or seeking to improve the release characteristics of an existing drug, our lyophilization and flash-release technology are there to help,” said Protheragen-ING’s Chief Scientist. ...
CD BioSciences can help scientists identify key regulators, decipher their molecular functions, elucidate their regulatory mechanisms, and translate these insights into cellular and animal models, paving the way for targeted drug discovery and therapy development. Through meticulous scientific rigor and cutting-edge technologies, CD BioSciences bridges the gap ...
In the rapidly evolving field of drug delivery systems, novel therapies are continuously being developed to enhance the effectiveness and precision of treatment. ...
Excipients for Transdermal and Mucosal Drug Delivery Systems Materials In addition to traditional drug delivery systems, CD Formulation leads in developing materials for transdermal and mucosal drug delivery systems. These advanced materials can enhance drug absorption and bioavailability through the skin and mucous membranes, ...
Good news from vascular medicine: the innovative drug Revacept can protect people with narrowed carotid arteries from both further strokes and dangerous bleeding. ...
The proceeds will enable ViGeneron to accelerate its proprietary viral vector-based gene therapy platforms and drive product development in its two lead ophthalmic gene therapy programs. ...
Cellworks Group Inc., a leader in Personalized Therapy Biosimulation, today announced the launch of its Precision Drug Development business units aimed at accelerating time-to-market for drug development and reviving previously studied but unapproved pharmaceutical assets through predictive biosimulation. ...
” “I am excited to join Ncardia and Cellistic, leaders in iPSC space” Gustavo Mahler, Ncardia and Cellistic CEO, said, “our focus will be to accelerate the commercialization of new applications for discovery and therapeutic development that should transform the drug development and cell therapy landscape” Stefan Braam, Ncardia ...
The associated patents broadly cover foundational elements for the rapid, targeted delivery of drugs, including gene therapies, throughout the gastrointestinal tract. ...
“Antengene believes that cancer treatments involving the rational combination of immuno-oncology drugs and targeted therapies may offer the greatest opportunity for substantial advances in treatment outcomes for patients with cancer,” said Dr. ...
In recent years, CRISPR technology has significantly promoted the innovation of gene therapy for blood diseases, tumors, genetic diseases, and other diseases, which has become a powerful tool in the field of scientific research. ...
This drug, produced in spirulina, contains an antibody cocktail for SARS-CoV-2, the virus that causes COVID-19. ...
“This study demonstrates the power of using Cellworks personalized therapy biosimulation to gain insight into individual patient mutanome, drug resistance pathways and novel biomarkers that determine their drug response and resistance to better inform treatment decisions for MDS ...
Drug therapy is one of the major modalities for cancer treatment. However, drug resistance may reveal whether it is chemotherapy drugs, targeted drugs, or immunotherapy drugs. ...
Cellworks Group Inc. a leader in Precision Drug Development and Personalized Therapy Biosimulation, today announced results from a Cellworks biosimulation pilot study, which examined the impact of mismatch repair deficiency (MRD) on survival of temozolomide (TMZ)-treated patients with MGMT methylated (m-MGMT) glioblastoma (GBM). ...
Although blood cholesterol can be lowered using a number of marketed drugs, of which statins are the leading drugs, only 38% of patients taking these drugs are achieving the low-density lipoprotein cholesterol goals set by the National Cholesterol Education Program (NCEP). Fu rthermore, patients with homozygous familial hypercholesterolemia who ...